John Haanen

59PUBLICATIONS
297CO-AUTHORS
Tumour immunologyGene and molecular therapyCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (59)

|Jun 25, 2026
Immune checkpoint inhibitor therapy after tumor-infiltrating lymphocytes in unresectable melanoma.

|May 18, 2026
Phenotypic and Functional Characteristics of CD8+ T Cells Predict Clinical Outcome Following TIL Therapy in a Randomized Phase III Trial in Advanced Melanoma.

|Mar 27, 2026
Publisher Correction: Clinical development of cancer vaccines.

John B Haanen, Ton N M Schumacher, Jonathan C Kagan

|Mar 12, 2026
Clinical development of cancer vaccines.

John B Haanen, Ton N M Schumacher, Jonathan C Kagan

|Mar 03, 2026
Where is the data? Delayed and chronic irAE surveillance and management after cessation of ICIs: expert insights from SITC on survivorship care and the need for long-term data.

Tessa F Flores, Emily S Tonorezos, Shailender Bhatia

|Feb 05, 2026
NEO-STIM advances personalized neoantigen-specific adoptive T cell therapy.

Divya Lenkala, Jessica Kohler, Brian McCarthy

Pageof 10

Frequent Collaborators

21 joint publications

Ton N Schumacher

11 joint publications

Christian U Blank

7 joint publications

Michel W Wouters

6 joint publications

Myriam Chalabi